29. According to the Institute for Safe Medication Practices (ISMP), which of the following is classified as a high-alert medication?
Answer: A
Methotrexate (Rheumatrex) is classified as a high-alert medication.
High-alert medications are those that have a higher risk of causing significant harm if used inappropriately. Methotrexate (Rheumatrex) is recognized by the Institute for Safe Medication Practices (ISMP) as a high-alert medication due to its potential for serious adverse effects, particularly when dosing is incorrect or monitoring is inadequate.
A) Methotrexate (Rheumatrex)
This option is correct as Methotrexate is indeed classified as a high-alert medication by the ISMP. It is utilized in various therapies, including cancer treatment and autoimmune diseases, but it poses significant risks such as toxicity and organ damage if mismanaged.
B) Methylprednisolone (Medrol)
Methylprednisolone, while a potent corticosteroid, is not classified as a high-alert medication by the ISMP. Although it has potential side effects, the risks associated with its use do not place it in the same category as Methotrexate, which requires more stringent precautions.
C) Meloxicam (Mobic)
Meloxicam is a nonsteroidal anti-inflammatory drug (NSAID) and is not classified as a high-alert medication. While it carries risks, particularly in patients with certain comorbidities, it does not have the same high-risk profile that necessitates the heightened awareness associated with high-alert medications like Methotrexate.
D) Methimazole (Tapazole)
Methimazole is used to manage hyperthyroidism but is not classified as a high-alert medication. The potential risks associated with its use do not elevate it to the same level of concern as Methotrexate, which is known for its serious toxicities.
Conclusion
Methotrexate (Rheumatrex) is correctly identified as a high-alert medication due to the significant risks associated with its use. In contrast, the other options do not meet the criteria established by the ISMP for high-alert status, highlighting the unique safety concerns surrounding Methotrexate. Understanding these classifications is critical for healthcare professionals in ensuring patient safety during medication administration.